JENBURPHPharmaceuticals
Jenburkt Pharmaceuticals Ltd — PE Ratio & Valuation Analysis
₹955.45
+0.34%
Current P/E15.33xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E20.6x25.6% below avg
✅
51.7% Discount to Industry
JENBURPH P/E 15.33x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2024 | ₹58.86 | ₹1215 | 20.6x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Jenburkt Pharmaceuticals Ltd Valuation
Jenburkt Pharmaceuticals Ltd (JENBURPH) currently trades at 15.33x earnings. The Pharmaceuticals sector average PE is 31.77x. JENBURPH is trading at a discount to peers — may indicate relative value. Historically, JENBURPH has traded at an average PE of 20.6x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
19.87%
Dividend Yield
1.57%
More on Jenburkt Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.